Furthermore, a number of studies demonstrate that HMGB1 is released by liver parenchymal cells, leading to TLR4/MyD88-mediated cytokines release from hepatocytes in the early stage of NAFLD, which precedes the occurrence of kupffer cell-mediated inflammation (Li et al. 2011). Here, MYD88 is linked to metabolic dysfunction-associated steatotic liver disease.